Prostate cancer study investigates why race matters in treatment success
Knowledge-focused
Recruiting now
This study follows 130 men with metastatic prostate cancer who are receiving standard treatment with abiraterone and prednisone. Researchers want to see if a person's race or ethnicity affects how well the treatment works, by tracking PSA levels and genetic differences. The goal …
Phase: PHASE2 • Sponsor: Martha Mims • Aim: Knowledge-focused
Last updated May 26, 2026 03:22 UTC